GA
IDXX icon

Geller Advisors’s Idexx Laboratories IDXX Stock Holding History

Geller Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,446
Closed -$1.23M – 261
2023
Q2 		$1.23M Buy
2,446
+196
+9% +$93.9K 0.15% 41
2023
Q1 		$1.13M Buy
2,250
+62
+3% +$29.7K 0.17% 27
2022
Q4 		$893K Sell
2,188
-77
-3% -$29.9K 0.15% 31
2022
Q3 		$738K Buy
2,265
+90
+4% +$33.1K 0.16% 31
2022
Q2 		$763K Buy
2,175
+99
+5% +$40.4K 0.16% 34
2022
Q1 		$1.14M Sell
2,076
-12
-0.6% -$6.31K 0.21% 25
2021
Q4 		$1.38M Hold
2,088
– – 0.27% 25
2021
Q3 		$1.3M Buy
+2,088
New +$1.4M 0.28% 22

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geller Advisors's IDXX Position: Q3 2023 in Review

Geller Advisors sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 2,446 shares — an estimated $1.23M sold.

Geller Advisors first reported a position in IDXX in Q3 2021 and held it in 8 quarters. The position peaked at $1.38M in Q4 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Geller Advisors reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Geller Advisors sold 2,446 Idexx Laboratories shares in Q3 2023, an estimated $1.23M.
  • Geller Advisors first reported a position in Idexx Laboratories in Q3 2021 and held it in 8 quarters.
  • Geller Advisors's Idexx Laboratories position peaked at $1.38M in Q4 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Geller Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.